![Thomas Stankovich](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas Stankovich
Financieel Directeur/CFO bij
ReShape Weightloss, Inc.
Profiel
Thomas Stankovich is currently Chief Financial Officer & Senior Vice President at ReShape Weightloss, Inc. since 2019.
Former roles include President, Chief Executive Officer, CFO & CAO at ReShape Lifesciences, Inc. in 2022; Chief Financial Officer & Senior Vice President at Ribapharm, Inc. from 2001 to 2003; Chief Financial Officer, Treasurer & EVP at Cobalis Corp.
from 2005 to 2006; Chief Financial Officer, Secretary & VP at Response Genetics, Inc. from 2006 to 2010; Chief Financial Officer & Secretary at Obalon Therapeutics, Inc.; Chief Financial Officer & Senior Vice President at MP Biomedicals LLC from 2003 to 2005; Chief Financial Officer & Vice President at ICN International AG from 2000 to 2001; Head-Controlling & Vice President at ICN from 1986 to 2011; and Chief Financial Officer at Vyome Holdings, Inc. Education includes undergraduate studies at California State University-Northridge.
Actieve functies van Thomas Stankovich
| Bedrijven | Functie | Begin |
|---|---|---|
ReShape Weightloss, Inc.
 ReShape Weightloss, Inc. Medical SpecialtiesHealth Technology Develops and manufactures medical devices for the treatment of obesity | Financieel Directeur/CFO | 30-10-2019 |
Eerdere bekende functies van Thomas Stankovich
| Bedrijven | Functie | Einde |
|---|---|---|
| RESPONSE GENETICS, INC | Financieel Directeur/CFO | 02-04-2010 |
Cobalis Corp.
 Cobalis Corp. Pharmaceuticals: OtherHealth Technology Develops anti allergy medications | Financieel Directeur/CFO | 18-12-2006 |
MP Biomedicals LLC
 MP Biomedicals LLC BiotechnologyHealth Technology Manufactures and sells biotechnology research products | Financieel Directeur/CFO | 01-12-2005 |
Ribapharm, Inc.
 Ribapharm, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and markets antiviral and anticancer pharmaceuticals | Financieel Directeur/CFO | 01-01-2003 |
ICN International AG | Financieel Directeur/CFO | 01-01-2001 |
Opleiding van Thomas Stankovich
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
23
Eerstegraads connecties
10
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 10 |
|---|---|
Ribapharm, Inc.
Ribapharm, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and markets antiviral and anticancer pharmaceuticals | Health Technology |
Cobalis Corp.
Cobalis Corp. Pharmaceuticals: OtherHealth Technology Develops anti allergy medications | Health Technology |
Response Genetics, Inc.
 Response Genetics, Inc. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical and diagnostic services | Health Technology |
Obalon Therapeutics, Inc.
 Obalon Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops medical balloon technology for weight loss therapy | Health Technology |
MP Biomedicals LLC
MP Biomedicals LLC BiotechnologyHealth Technology Manufactures and sells biotechnology research products | Health Technology |
California State University-Northridge
 California State University-Northridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ICN International AG | |
ICN/DN Europe | |
ReShape Weightloss, Inc.
ReShape Weightloss, Inc. Medical SpecialtiesHealth Technology Develops and manufactures medical devices for the treatment of obesity | Health Technology |
ReShape Lifesciences, Inc.
 ReShape Lifesciences, Inc. Medical SpecialtiesHealth Technology Develops medical devices for the treatment of obesity | Health Technology |
